FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eugenio Marcuello

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Occupations

Pharmacogenetics

Co-author Network

Publications

TOP 3
Manuel Benavides; Enrique Cabrera; Juan Manuel Campos; Alfredo Carrato; Rosario Dueñas; Arantxa Etxeberría; Silvia Gil-Calle; Auxiliadora Gómez; Ma José Gómez; Encarna González-Flores; Inmaculada Guasch; Eugenio Marcuello; Bartomeu Massutí; Carles Pericay; Bernardo Queralt; Juan José Reina; Manuel Valladares-Ayerbes; Jordi Alfaro; Jorge Aparicio; Enrique Aranda
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
Eduardo Díaz-Rubio; Carlos Fernández-Martos; Auxiliadora Gómez España; Encarnación González; José Luis Manzano; Eugenio Marcuello; Purificación Martínez de Prado; Bartomeu Massutí; Clara Montagut; Margarita Reboredo; Fernando Rivera; M José Safont; Javier Sastre; Enrique Aranda; Antonio Arrivi; Inmaculada Bando; Manuel Benavides; Andrés Cervantes
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.
Javier Sastre; Josep M Tabernero; Manuel Valladares; Marta Vidaurreta; Albert Abad; Enrique Aranda; Antonio Arrivi; Manuel Benavides; Carlos Fernández-Martos; Manuel Gallén; Auxiliadora Gómez España; Encarnación González; M Luisa Maestro; Eugenio Marcuello; Bartomeu Massuti; Fernando Rivera; Eduardo Díaz-Rubio
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eugenio Marcuello (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Manuel Benavides; Enrique Cabrera; Juan Manuel Campos; Alfredo Carrato; Rosario Dueñas; Arantxa Etxeberría; Silvia Gil-Calle; Auxiliadora Gómez; Ma José Gómez; Encarna González-Flores; Inmaculada Guasch; Eugenio Marcuello; Bartomeu Massutí; Carles Pericay; Bernardo Queralt; Juan José Reina; Manuel Valladares-Ayerbes; Jordi Alfaro; Jorge Aparicio; Enrique Aranda
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
Clinical colorectal cancer 2012;11(3):200-6.
2012: Eduardo Díaz-Rubio; Carlos Fernández-Martos; Auxiliadora Gómez España; Encarnación González; José Luis Manzano; Eugenio Marcuello; Purificación Martínez de Prado; Bartomeu Massutí; Clara Montagut; Margarita Reboredo; Fernando Rivera; M José Safont; Javier Sastre; Enrique Aranda; Antonio Arrivi; Inmaculada Bando; Manuel Benavides; Andrés Cervantes
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.
PloS one 2012;7(10):e47345.
2012: Javier Sastre; Josep M Tabernero; Manuel Valladares; Marta Vidaurreta; Albert Abad; Enrique Aranda; Antonio Arrivi; Manuel Benavides; Carlos Fernández-Martos; Manuel Gallén; Auxiliadora Gómez España; Encarnación González; M Luisa Maestro; Eugenio Marcuello; Bartomeu Massuti; Fernando Rivera; Eduardo Díaz-Rubio
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
The oncologist 2012;17(7):947-55.
2012: Javier Sastre; Manuel Valladares-Ayerbes; Manuel Benavides; Eduardo Díaz-Rubio; Cristina Grávalos; Manuel Hidalgo; José L Manzano; Eugenio Marcuello; Bartomeu Massuti; Fernando Rivera; Enrique Aranda
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
The oncologist 2012;17(3):339-45.
2012: Eduardo Díaz-Rubio; Rosario Dueñas; Pilar Escudero; Carlos Fernández-Martos; Manuel Gallén; Auxiliadora Gómez España; Encarnación González; Adelaida Lacasta; Marta Llanos; Amelia López-Ladrón; Ferrán Losa; Eugenio Marcuello; Purificación Martínez de Prado; Bartomeu Massutí; Fernando Rivera; Maria J Safont; Javier Sastre; Josep Tabernero; Manuel Valladares; Albert Abad; Antonio Antón; Enrique Aranda; Antonio Arrivi; Manuel Benavides; Andrés Cervantes
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.
The oncologist 2012;17(1):15-25.
2011: David Páez; Laia Pare Brunet; Lourdes Pertriz; Juliana Salazar; Eduardo Targarona; Agustí Barnadas; Elisabeth del Rio; Eugenio Marcuello; Montserrat Baiget
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
International journal of radiation oncology, biology, physics 2011;81(5):1319-27.
2011: Eugenio Marcuello; D Páez; Laia Pare Brunet; Juliana Salazar; A Sebio; Elisabeth del Rio; Montserrat Baiget
A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer.
British journal of cancer 2011;105(1):53-7.
2010: David Páez; Laia Pare Brunet; Albert Altés; Francesc Josep Sancho-Poch; Lourdes Petriz; Jordi Garriga; Josep Maria Monill; Juliana Salazar; Elisabeth del Rio; Agustí Barnadas; Eugenio Marcuello; Montserrat Baiget
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.
Journal of cancer research and clinical oncology 2010;136(11):1681-9.
2010: David Paez; Laia Pare Brunet; Iñigo Espinosa; Juliana Salazar; Elisabeth del Rio; Agustí Barnadas; Eugenio Marcuello; Montserrat Baiget
Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy?
Cancer science 2010;101(9):2048-53.
2010: Laia Pare Brunet; David Paez; Juliana Salazar; Elisabeth del Rio; Eduardo Tizzano; Eugenio Marcuello; Montserrat Baiget
Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy.
British journal of clinical pharmacology 2010;70(2):268-72.
2010: Carlos Fernández-Martos; Carles Pericay; Jorge Aparicio; Antonieta Salud; Mariajose Safont; Bertomeu Massuti; Ruth Vera; Pilar Escudero; Joan Maurel; Eugenio Marcuello; Jose Luis Mengual; Eugenio Saigi; Rafael Estevan; Moises Mira; Sonia Polo; Ana Hernandez; Manuel Gallen; Fernando Arias; Javier Serra; Vicente Alonso
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):859-65.
2010: Humberto Villavicencio; Oscar Rodriguez Faba; Joan Palou; Luis Gausa; Ferran Algaba; Eugenio Marcuello
Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: management and results at long-term follow-up.
Urologia internationalis 2010;85(3):281-6.
2008: Laia Pare Brunet; Eugenio Marcuello; Albert Altés; E del Río; L Sedano; J Salazar; A Cortés; A Barnadas; Montserrat Baiget
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy.
British journal of cancer 2008;99(7):1050-5.
2008: Laia Pare Brunet; Juliana Salazar; Elisabeth del Rio; Montserrat Baiget; Albert Altés; Eugenio Marcuello; David Paez; Agustí Barnadas
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3468; author reply 3468-9.
2008: Janelle Hoskins; Eugenio Marcuello; Albert Altes; Sharon Marsh; Taylor Maxwell; Derek J Van Booven; Laia Pare Brunet; Robert Culverhouse; howard mcleod; Montserrat Baiget
Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1788-96.
2008: Albert Abad; Bartomeu Massuti; Antonio Antón; Maria Eugenia Vega; Ana L Yuste; Eugenio Marcuello; José Luis Manzano; Vicente Alonso; Alfredo Carrato; Mercedes Martinez-Villacampa; Josep Tabernero; Enrique Aranda; Fernando Rivera; Eduardo Díaz-Rubio
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(2):286-92.
2007: Guillermo Marín-Hargreaves; Vicente Artigas; José A González; Carmen Martínez; Eugenio Marcuello; Manuel Trías-Folch
[Inversion of the sequence of surgery after neoadjuvant chemotherapy for synchronous liver metastases from colorectal cancer].
Cirugía española 2007;82(4):235-7.
2007: Vicente Artigas; Guillermo Marín-Hargreaves; Eugenio Marcuello; Albert Pey; José A González; Manuel Rodríguez; Antonio Moral; José María Monill; José Sancho; Carles Pericay; Manuel Trias
[Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital].
Cirugía española 2007;81(6):339-44.
2006: María Virtudes Céspedes; Francesc Josep Sancho; Sílvia Guerrero; Matilde Parreño; Isolda Casanova; Miguel Angel Pavón; Eugenio Marcuello; Manuel Trias; Marta Cascante; Gabriel Capellà; Bafalluy Mangues
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
Carcinogenesis 2006;27(11):2190-200.
2006: Esther Roé; María Pilar García Muret; Eugenio Marcuello; Jaume Capdevila; Cinta Pallarés; Agustín Alomar
Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients.
Journal of the American Academy of Dermatology 2006;55(3):429-37.
2006: Eugenio Marcuello; Albert Altés; Anna Menoyo; E Del Rio; Montserrat Baiget
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
Cancer chemotherapy and pharmacology 2006;57(6):835-40.
2006: Isolda Casanova; Matilde Parreño; Lourdes Farré; Sílvia Guerrero; María Virtudes Céspedes; Miguel Angel Pavon; Francesc Josep Sancho; Eugenio Marcuello; Manuel Trias; Bafalluy Mangues
Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas.
International journal of cancer. Journal international du cancer 2006;118(10):2381-9.
2005: Javier Sastre; Eugenio Marcuello; Bartomeu Masutti; Matilde Navarro; Silvia Gil; Antonio Antón; Albert Abad; Enrique Aranda; Joan Maurel; Manuel Valladares; Inmaculada Maestu; Alfredo Carrato; José María Vicent; Eduardo Díaz-Rubio
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3545-51.
2005: Albert Abad; Alfredo Carrato; Matilde Navarro; Javier Sastre; Andrés Cervantes; Antonio Antón; Mercedes Martinez-Villacampa; Eugenio Marcuello; Bartomeu Massutí; Enrique Aranda; José Luis Manzano; José Luis Guallar; Eduardo Diaz-Rubio
Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer.
Clinical colorectal cancer 2005;4(6):384-9.
2004: Eugenio Marcuello; Albert Altés; Elisabeth del Rio; Angeles César; Anna Menoyo; Montserrat Baiget
Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
International journal of cancer. Journal international du cancer 2004;112(5):733-7.
2004: Eugenio Marcuello; Albert Altés; Anna Menoyo; Elisabeth del Rio; M Gómez-Pardo; Montserrat Baiget
UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
British journal of cancer 2004;91(4):678-82.
2004: Enrique Aranda; Alfredo Carrato; Andrés Cervantes; Javier Sastre; M A Gómez; Albert Abad; Bartomeu Masutti; F Ribera; Eugenio Marcuello; L Pronk; Miquel Balcells; Eduardo Díaz-Rubio
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(4):559-67.
2003: Rosa-Ana Risques; Victor Moreno; Maria Ribas; Eugenio Marcuello; Gabriel Capellà; Miguel A Peinado
Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer.
Cancer research 2003;63(21):7206-14.
2003: Antonio Antón; E Aranda; Alfredo Carrato; Eugenio Marcuello; B Massutti; A Cervantes; A Abad; J Sastre; C Fenández-Martos; Manel Gallén; E Díaz-Rubio; L Huarte; Miquel Balcells
Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II study.
Methods and findings in experimental and clinical pharmacology 2003;25(8):639-43.
2003: E Pieras; J Palou; J Salvador; A Rosales; Eugenio Marcuello; Humberto Villavicencio
Management and prognosis of transitional cell carcinoma superficial recurrence in muscle-invasive bladder cancer after bladder preservation.
European urology 2003;44(2):222-5; discussoion 225.
2002: M Palicio; Judith Balmaña; S González; Ignacio Blanco; Eugenio Marcuello; Miguel A Peinado; G Julià; Josep Ramon Germà; J J López López; Joan Brunet; Gabriel Capellà
Mismatch repair gene analysis in Catalonian families with colorectal cancer.
Journal of medical genetics 2002;39(6):E29.
2002: Xavier Garcia del Muro; Eugenio Marcuello; J Gumá; Luis Paz-Ares; Miguel Angel Climent; Joan Carles; M Sánchez Parra; J L Tisaire; Pablo Maroto; J R Germá
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer.
British journal of cancer 2002;86(3):326-30.
2001: Rosa-Ana Risques; Victor Moreno; Eugenio Marcuello; J Petriz; J A Cancelas; Francesc Josep Sancho; A Torregrosa; G Capella; Miguel A Peinado
Redefining the significance of aneuploidy in the prognostic assessment of colorectal cancer.
Laboratory investigation; a journal of technical methods and pathology 2001;81(3):307-15.
2001: Manel Esteller; S González; Rosa-Ana Risques; Eugenio Marcuello; Bafalluy Mangues; Josep Ramon Germà; James G Herman; Gabriel Capellà; Miguel A Peinado
K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):299-304.
2000: I González-García; Victor Moreno; M Navarro; Joan Martí Ragué; Eugenio Marcuello; C Benasco; O Campos; Gabriel Capellà; Miguel A Peinado
Standardized approach for microsatellite instability detection in colorectal carcinomas.
Journal of the National Cancer Institute 2000;92(7):544-9.
2000: M Palicio; Ignacio Blanco; S Tórtola; I González; Eugenio Marcuello; Joan Brunet; F Lluis; J J González-Aguilera; Miguel A Peinado; G Capella
Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer.
British journal of cancer 2000;82(3):535-7.
2000: Judith Balmaña; Joan Brunet; Gabriel Capellà; D González; M Palicio; Francesc Josep Sancho; Carles Pericay; Juan José López López; Eugenio Marcuello
[Identification of 2 families with hereditary nonpolyposis colonic cancer (HNPCC) and the Amsterdam criteria. Relevance of the genealogic tree and follow-up].
Medicina clínica 2000;114(2):56-9.
1999: R Arribas; Maria Ribas; Rosa-Ana Risques; Laia Masramon; S Tórtola; Eugenio Marcuello; Gemma Aiza; Rosa Miró; Gabriel Capellà; Miguel A Peinado
Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3454-9.
1999: S Tórtola; Eugenio Marcuello; Rosa-Ana Risques; S González; Gemma Aiza; Gabriel Capellà; Miguel A Peinado
Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer.
Oncogene 1999;18(30):4383-7.
1999: E Díáz-Rubio; Javier Sastre; Albert Abad; Matilde Navarro; Enrique Aranda; Alfredo Carrato; Manel Gallén; Eugenio Marcuello; J Rifá; T Massuti; Andrés Cervantes; Antonio Antón; Carlos Fernández-Martos
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):35-40.
1999: Silvia Tortola; Eugenio Marcuello; I González; G Reyes; R Arribas; Gemma Aiza; Francesc Josep Sancho; Miguel A Peinado; G Capella
p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1375-81.
1998: S Tórtola; Gabriel Capellà; Eugenio Marcuello; K Günther; Gemma Aiza; Laia Masramon; M A Reymond; Miguel A Peinado
Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment.
Laboratory investigation; a journal of technical methods and pathology 1998;78(3):309-17.
1997: Albert Abad; Matilde Navarro; Javier Sastre; Eugenio Marcuello; Enrique Aranda; Manel Gallén; C Fernandez-Martos; C Martín; Eduardo Diaz-Rubio
A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 10):53-7.
1997: Pablo Maroto; Josep Tabernero; Humberto Villavicencio; R Mesía; Eugenio Marcuello; F J Solé-Balcells; C Sola; J Mora; Ferran Algaba; C Pérez; Xavier León; Juan José López López
Growing teratoma syndrome: experience of a single institution.
European urology 1997;32(3):305-9.